U.S. pharma giant copyright scrapped two experimental weight loss supplements past yr—a once-everyday pill, lotiglipron, on account of elevated liver enzymes and a 2 times-daily pill, danuglipron, resulting from strong Uncomfortable side effects—but CEO Albert Bourla has reported the